Showing results (91-100 of 188) with videos related to
Sort By:
Pageof 19
Neurology|November 1, 1996
Low-dose oral methotrexate in chronic progressive multiple sclerosis: analyses of serial MRIsD E Goodkin, R A Rudick, S VanderBrug Medendorp, et al.Neurology|October 1, 1993
In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon betaR A Rudick, C S Carpenter, D L Cookfair, et al.The Journal of Continuing Education in the Health Professions|June 20, 2007
Developing a mentorship program for clinical researchersCarol E Blixen, Klara K Papp, Alan L Hull, et al.Archives of Neurology|May 1, 1997
Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosisD C Mohr, D E Goodkin, W Likosky, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2005
Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implicationsRobert J Fox, Elizabeth Fisher, Jean Tkach, et al.Annals of Neurology|February 5, 2013
Predictors of long-term outcome in multiple sclerosis patients treated with interferon βRobert A Bermel, Xiaojun You, Pamela Foulds, et al.JAMA Neurology|April 20, 2013
Reliability of classifying multiple sclerosis disease activity using magnetic resonance imaging in a multiple sclerosis clinicEdru Erbayat Altay, Elizabeth Fisher, Stephen E Jones, et al.The International Journal of Neuroscience|October 2, 2014
Experience with fingolimod in clinical practiceCarrie M Hersh, Claire Hara-Cleaver, Richard A Rudick, et al.Journal of Leukocyte Biology|August 22, 2007
Novel interferon-beta-induced gene expression in peripheral blood cellsM R Sandhya Rani, Jennifer Shrock, Swathi Appachi, et al.Neurology|February 1, 1996
Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trialL A Rolak, R W Beck, D W Paty, et al.Pageof 19